1
|
Nakamura M, Kuriyama N, Tanaka Y, Yamazaki S, Kawasaki T, Muramatsu T, Kadota K, Ashikaga T, Takahashi A, Otsuji S, Ando K, Ishida M, Nakamura S, Ito Y, Iijima R, Nakazawa G, Shite J, Honye J, Ako J, Yokoi H, Kozuma K, Otake H, Masumura K, Yamada T, Sotomi Y. Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry. Cardiovasc Interv Ther 2025:10.1007/s12928-025-01130-9. [PMID: 40354027 DOI: 10.1007/s12928-025-01130-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2025] [Accepted: 04/30/2025] [Indexed: 05/14/2025]
Abstract
Evaluation of calcified lesions by intravascular imaging has revealed that atherectomy devices have only limited impact. However, subsequent use of coronary intravascular lithotripsy (IVL) may increase treatment effectiveness without increasing risk of complications. This study was designed to evaluate the safety and effectiveness of IVL use after atherectomy in severely calcified coronary lesions as pre-treatment for drug-eluting stents (DES). The Dual-Prep registry is a multicenter, prospective registry of consecutive image-guided percutaneous coronary interventions (PCI). The primary effectiveness and safety endpoints were procedural success (residual stenosis < 50% by quantitative coronary angiography) without an in-hospital major adverse cardiac event (MACE) and 30-day freedom from MACE, respectively. Baseline vessel calcification score and final DES expansion were evaluated by optical coherence tomography (OCT). A total of 118 patients with 120 lesions were enrolled at 20 sites. The calcification score of lesions after atherectomy by core-lab assessment was 4.0 in all cases. Rotational atherectomy was applied prior to IVL in 83.9% cases with mean burr size of 1.57 ± 0.20 mm; IVL was subsequently successfully delivered in all cases (mean balloon diameter 3.02 ± 0.45 mm), followed by DES deployment (mean diameter 3.19 ± 0.51 mm, length of 36.3 ± 16.0 mm). The primary efficacy and safety endpoints were met in 98.3% and 98.3% of cases, respectively. A DES expansion index < 0.8 was seen in 42.2%, and an eccentricity index < 0.7 was not observed in any patient. In severely calcified lesions, image-guided atherectomy followed by IVL lesion preparation demonstrated high procedural success rates and satisfactory non-eccentric stent expansion. This approach may be considered for lesions where an 'IVL-first' strategy may not be feasible. jRCT1032230384 (Oct 7, 2023).
Collapse
Affiliation(s)
- Masato Nakamura
- Division of Minimally Invasive Treatment in Cardiovascular Medicine, Toho University Ohashi Medical Center, 2-22-36, Ohashi, Meguro-Ku, Tokyo, 153-8515, Japan.
| | - Nehiro Kuriyama
- Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan
| | - Yutaka Tanaka
- Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan
| | - Seiji Yamazaki
- Department of Cardiology, Sapporo Higashi Tokushukai Hospital, Hokkaido, Japan
| | - Tomohiro Kawasaki
- Department of Cardiology, Tenjinkai Shin-Koga Hospital, Fukuoka, Japan
| | - Takashi Muramatsu
- Department of Cardiology, Fujita Health University Hospital, Aichi, Japan
| | - Kazushige Kadota
- Department of Cardiology, Kurashiki Central Hospital, Okayama, Japan
| | - Takashi Ashikaga
- Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan
| | - Akihiko Takahashi
- Department of Cardiology, Sakurakai Takahashi Hospital, Hyogo, Japan
| | - Satoru Otsuji
- Department of Cardiology, Higashi Takarazuka Satoh Hospital, Hyogo, Japan
| | - Kenji Ando
- Department of Cardiology, Kokura Memorial Hospital, Fukuoka, Japan
| | - Masaru Ishida
- Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Iwate, Japan
| | | | - Yoshiaki Ito
- Department of Cardiology, Saiseikai Yokohamashi Tobu Hospital, Kanagawa, Japan
| | - Raisuke Iijima
- Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan
| | - Gaku Nakazawa
- Department of Cardiology, Kindai University Hospital, Osaka, Japan
| | - Junya Shite
- Department of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
| | - Junko Honye
- Department of Cardiology, Kikuna Memorial Hospital, Kanagawa, Japan
| | - Junya Ako
- Department of Cardiovascular Medicine, Kitasato University Hospital, Kanagawa, Japan
| | - Hiroyoshi Yokoi
- Cardiovascular Center, Fukuoka Sanno Hospital, Fukuoka, Japan
| | - Ken Kozuma
- Department of Cardiology, Teikyo University Hospital, Tokyo, Japan
| | - Hiromasa Otake
- Graduate School of Medicine/Division of Cardiovascular Medicine, Kobe University, Hyogo, Japan
| | - Kazuho Masumura
- Department of Medical Innovation, Osaka University Hospital, Osaka, Japan
| | - Tomomi Yamada
- Department of Medical Innovation, Osaka University Hospital, Osaka, Japan
| | - Yohei Sotomi
- Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
2
|
Gawalkar AA, Akkineni KP, Vijayvergiya R, Karki P. Advantages of Orbital Atherectomy: A Case Series. Catheter Cardiovasc Interv 2025; 105:1409-1414. [PMID: 40033673 DOI: 10.1002/ccd.31474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Revised: 02/13/2025] [Accepted: 02/23/2025] [Indexed: 03/05/2025]
Abstract
Severe coronary calcification poses a significant challenge during percutaneous coronary intervention. Rotational atherectomy is widely used for calcium ablation because of its efficacy, cost-effectiveness and availability. However, orbital atherectomy (OA), with its unique design and mechanism, is the treatment of choice in certain subsets of calcific lesions. Through a case-based approach, we highlighted the unique advantages of OA in modifying calcified lesions. We illustrated three cases with heavily calcified coronary arteries where OA had to be chosen in preference to other calcium modification techniques. We also included imaging evidence to demonstrate the efficacy of OA in calcium modification. Calcific coronary lesions need a multi-pronged approach for optimal management. In certain situations like a mismatch in size between the main vessel and side branch, eccentric calcium with unfavorable wire bias and calcium in close proximity to a stented segment, OA can be used to successfully modify the calcium with lesser risk of complications.
Collapse
Affiliation(s)
| | | | - Rajesh Vijayvergiya
- Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Pragya Karki
- Post Graduate Institute of Medical Education and Research, Chandigarh, India
| |
Collapse
|
3
|
Pesarini G, Hellig F, Seth A, Shlofmitz RA, Ribichini FL. Percutaneous coronary intervention for calcified and resistant lesions. EUROINTERVENTION 2025; 21:e339-e355. [PMID: 40191879 PMCID: PMC11956026 DOI: 10.4244/eij-d-24-00195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Accepted: 09/19/2024] [Indexed: 04/09/2025]
Abstract
Relevant calcified coronary artery disease (CCAD) may be present in around 20% of patients undergoing percutaneous coronary interventions, and it is known to add procedural challenges and risks. Careful patient selection and specific expertise in multimodality imaging and plaque modification techniques are required to plan and adopt the most appropriate therapeutic strategy. This review aims to present the contemporary clinical approach and procedural planning for CCAD patients, describing the available tools and strategies in view of the most recent scientific evidence.
Collapse
Affiliation(s)
- Gabriele Pesarini
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| | - Farrel Hellig
- Netcare Sunninghill Hospital, Sandton, South Africa
- University of Cape Town, Cape Town, South Africa
| | - Ashok Seth
- Fortis Escorts Heart Institute, New Delhi, India
| | | | | |
Collapse
|
4
|
Cassese S, Simonetti F, Covarrubias HAA, Janisch M, Joner M, Kufner S, Lenz T, Pellegrini C, Rheude T, Sager H, Schunkert H, Starnecker F, Voll F, Xhepa E, Kastrati A, Kessler T. Intracoronary stenting and additional results achieved by shockWAVE coronary lithotripsy: design and rationale of ISAR-WAVE trial. Am Heart J 2025; 282:1-12. [PMID: 39710352 DOI: 10.1016/j.ahj.2024.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Revised: 12/18/2024] [Accepted: 12/18/2024] [Indexed: 12/24/2024]
Abstract
BACKGROUND Percutaneous coronary intervention of severely calcified lesions is limited by inadequate stent expansion and poor clinical outcomes. Over the past decade, several devices and techniques have been developed for calcium modification and lesion preparation. Intravascular lithotripsy (IVL) is a novel tool in this context. Although numerous observational studies have been reported on this technique, randomized trials powered for clinical outcomes on the relative merits of IVL in patients with severely calcified lesions are lacking. STUDY DESIGN AND OBJECTIVES The ISAR-WAVE trial is a multicenter, prospective, randomized, single-blind controlled trial. The aim is to test whether IVL is superior to other calcium-modifying techniques (modified or super high-pressure balloon and atheroablative devices) in de novo severely calcified coronary lesions. The study is planned to enroll 666 patients. The primary endpoint is the composite of major cardiac and cerebrovascular adverse events defined as death, nonfatal myocardial infarction, nonfatal stroke and clinically indicated target vessel revascularization at 12 months. In addition to the individual components of the primary endpoint, secondary endpoints include also safety, quality of life and cost-effectiveness measures. CONCLUSIONS ISAR-WAVE is a multicenter, randomized trial designed to test the hypothesis that a strategy of IVL confers superior clinical performance compared to other calcium-modifying techniques in patients undergoing percutaneous intervention for a de novo severely calcified coronary artery lesion. TRIAL REGISTRATION ClilicalTrial.gov, NCT06369142.
Collapse
Affiliation(s)
- Salvatore Cassese
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
| | - Fiorenzo Simonetti
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
| | | | - Marion Janisch
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Michael Joner
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Sebastian Kufner
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Tobias Lenz
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Costanza Pellegrini
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Tobias Rheude
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Hendrik Sager
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Heribert Schunkert
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Fabian Starnecker
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Felix Voll
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Erion Xhepa
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
| | - Adnan Kastrati
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Thorsten Kessler
- Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| |
Collapse
|
5
|
Guardado J. Rotational atherectomy. Is it still the main tool in hard rock combat? Rev Port Cardiol 2025; 44:215-217. [PMID: 40024523 DOI: 10.1016/j.repc.2025.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2025] [Accepted: 02/21/2025] [Indexed: 03/04/2025] Open
Affiliation(s)
- Jorge Guardado
- Unidade de Hemodinâmica e Intervenção Cardiovascular - ULS da Região de Leiria, Leiria, Portugal; Heart Center - Hospital Cruz Vermelha Portuguesa, Lisboa, Portugal; Ucardio - Centro Clínico Unidade Cardiovascular, Riachos, Torres Novas, Portugal.
| |
Collapse
|
6
|
McInerney A, Hynes SO, Gonzalo N. Calcified Coronary Artery Disease: Pathology, Prevalence, Predictors and Impact on Outcomes. Interv Cardiol 2025; 20:e02. [PMID: 40028270 PMCID: PMC11865672 DOI: 10.15420/icr.2024.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Accepted: 08/22/2024] [Indexed: 03/05/2025] Open
Abstract
Calcified coronary artery disease is a common clinical finding and is visible angiographically in 25-30% of patients presenting for percutaneous coronary intervention. The presence of coronary calcium, even without coronary artery obstruction, confers an adverse clinical prognosis. Coronary calcium score on CT is additive in predicting risk of cardiovascular events beyond traditional scoring systems. Deposition of calcium in coronary arteries is initiated by the formation of an atherosclerotic plaque. Thereafter, multiple processes and pathways are involved, resulting in initial microcalcifications that coalesce into calcium sheets. Calcified nodules are thought to occur from rupture of these sheets. Calcified coronary stenoses requiring revascularisation result in greater target lesion failure and overall major adverse cardiovascular events than noncalcified lesions, regardless of the mode of revascularisation. Modifying calcium prior to stenting to optimise stent expansion is required and intracoronary imaging can greatly facilitate not only the detection of coronary calcium, but also the confirmation of adequate modification and stent optimisation. In this review, the authors examine the pathophysiology, prevalence, predictors and impact on outcomes of coronary calcium.
Collapse
Affiliation(s)
- Angela McInerney
- Department of Interventional Cardiology, Galway University HospitalGalway, Ireland
| | - Seán O Hynes
- Department of Pathology, University of GalwayGalway, Ireland
- Department of Anatomic Pathology, University Hospital GalwayGalway, Ireland
| | - Nieves Gonzalo
- 4. Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC)Madrid, Spain
| |
Collapse
|
7
|
Frizzell J, Kereiakes DJ. Calcified plaque modification during percutaneous coronary revascularization. Prog Cardiovasc Dis 2025; 88:39-52. [PMID: 39662758 DOI: 10.1016/j.pcad.2024.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Accepted: 12/01/2024] [Indexed: 12/13/2024]
Abstract
The presence and severity of calcified coronary plaque negatively impacts angiographic and clinical outcomes following percutaneous coronary intervention (PCI). Severe coronary calcification is associated with suboptimal stent delivery, deployment, apposition and expansion which can lead to in-stent restenosis and/or thrombosis. Severe coronary calcification is associated with incremental hazard for adverse clinical events, including death, during 5-10 years following PCI despite the use of new generation drug- eluting stents. Multiple technologies including high-pressure noncompliant and modified (cutting/scoring) balloons, atheroablative technologies (laser, rotational or orbital atherectomy), and more recently, intravascular lithotripsy have been used to modify calcified plaque and facilitate optimal coronary stent implantation. Intravascular imaging is critically important to determine the extent and distribution (superficial or deep) of coronary calcification and to aid selection and sequence for use of calcium modifying technologies. Unfortunately, large scale randomized comparative trials of calcium modifying technologies are limited and the relative safety and effectiveness of these modalities is poorly defined. Recent mechanistic and clinical data supporting the use of plaque modifying technologies are reviewed to provide insights into their optimal use.
Collapse
Affiliation(s)
- Jarrod Frizzell
- The Christ Hospital Heart & Vascular Institute and The Carl and Edyth Lindner Center for Research and Education, Cincinnati, Ohio, USA
| | - Dean J Kereiakes
- The Christ Hospital Heart & Vascular Institute and The Carl and Edyth Lindner Center for Research and Education, Cincinnati, Ohio, USA..
| |
Collapse
|
8
|
Khattak S, Sharma H, Khan SQ. Atherectomy Techniques: Rotablation, Orbital and Laser. Interv Cardiol 2024; 19:e21. [PMID: 39569386 PMCID: PMC11577869 DOI: 10.15420/icr.2024.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Accepted: 07/14/2024] [Indexed: 11/22/2024] Open
Abstract
Coronary artery disease remains the leading cause of morbidity and mortality worldwide despite advancements in percutaneous coronary intervention (PCI). With an increasing ageing population, there is a significant challenge in addressing severe calcification in atherosclerotic plaque during angioplasty. This review article focuses on atherectomy strategies such as rotational atherectomy (RA), orbital atherectomy (OA) and excimer laser coronary angioplasty (ELCA) aimed at modifying calcified lesions and improving PCI outcomes. RA modifies plaque through rotational ablation, OA uses eccentrically mounted diamond-coated crown and has a reduced entrapment risk compared to RA. ELCA uses pulsatile laser energy to precisely ablate plaque tissue. This review provides insights into the mechanisms, procedural techniques and clinical outcomes associated with these calcium modification techniques. The selection of appropriate devices and adequate training are crucial for optimising lesion modification and enhancing procedural success. Further research and standardised protocols are required to overcome challenges associated with using these devices and expand their usage in clinical practice.
Collapse
Affiliation(s)
- Sophia Khattak
- Department of Interventional Cardiology, Queen Elizabeth Hospital Birmingham, UK
- Institute of Cardiovascular Sciences, University of Birmingham Birmingham UK
| | - Harish Sharma
- Department of Interventional Cardiology, Queen Elizabeth Hospital Birmingham, UK
| | - Sohail Q Khan
- Department of Interventional Cardiology, Queen Elizabeth Hospital Birmingham, UK
- Institute of Cardiovascular Sciences, University of Birmingham Birmingham UK
| |
Collapse
|
9
|
Leite L. Orbital atherectomy: An expanded toolbox for coronary calcium management. Rev Port Cardiol 2024:S0870-2551(24)00281-6. [PMID: 39389356 DOI: 10.1016/j.repc.2024.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2024] [Accepted: 10/04/2024] [Indexed: 10/12/2024] Open
Affiliation(s)
- Luís Leite
- Cardiology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
| |
Collapse
|
10
|
Abdirashid M, Barbero U, Cavallino C, Maltese L, Bacci E, Reale D, Marengo G, De Benedictis M, Rametta F, Ugo F. Coronary Artery Calcium and Aging: Physiological Basis, Assessment, and Treatment Options in Percutaneous Coronary Intervention. J Cardiovasc Dev Dis 2024; 11:224. [PMID: 39057644 PMCID: PMC11277957 DOI: 10.3390/jcdd11070224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 06/26/2024] [Accepted: 06/27/2024] [Indexed: 07/28/2024] Open
Abstract
Coronary artery calcification is a complex anatomical and histological pathology with different pathways that contribute to calcium deposit and calcification progression. As part of the atherosclerotic process, extensive calcifications are becoming more common and are associated with poorer PCI outcomes if not properly addressed. Since no drug has shown to be effective in changing this process once it is started, proper knowledge of the underlying pathogenesis and how to diagnose and manage it is essential in contemporary coronary intervention. Atherosclerosis is a pandemic disease, quickly spreading across the world and not limited anymore to the industrialized Western world. In this paper, we review the role of intracoronary imaging and the main technologies available and propose a simple and rational algorithm for the choice of a preferential first strategy in the treatment of severely calcified coronary atherosclerosis, followed by three emblematic cases on how we successively applied it.
Collapse
Affiliation(s)
| | - Umberto Barbero
- Santissima Annunziata Hospital, 12038 Savigliano, Italy; (U.B.)
| | | | | | | | | | - Giorgio Marengo
- Santissima Annunziata Hospital, 12038 Savigliano, Italy; (U.B.)
| | | | | | | |
Collapse
|
11
|
Kirtane AJ, Ribichini F. Atherectomy for calcified plaques: orbital for most? Pros and cons. EUROINTERVENTION 2024; 20:e627-e629. [PMID: 38776145 PMCID: PMC11100497 DOI: 10.4244/eij-e-24-00014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/24/2024]
Affiliation(s)
- Ajay J Kirtane
- Columbia University Irving Medical Center, New York, NY, USA
- NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
| | - Flavio Ribichini
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| |
Collapse
|
12
|
Leone PP, Camaj A, Kini AS, Sharma SK, Colombo A. Any Advantage of Orbital Atherectomy if You Have Rotational Atherectomy? JACC Cardiovasc Interv 2023; 16:3047. [PMID: 38151319 DOI: 10.1016/j.jcin.2023.10.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Accepted: 10/31/2023] [Indexed: 12/29/2023]
|
13
|
Okamoto N, Egami Y, Matsunaga-Lee Y, Yano M, Nishino M. Reply: Any Advantage of Orbital Atherectomy if You Have Rotational Atherectomy? JACC Cardiovasc Interv 2023; 16:3048. [PMID: 38151320 DOI: 10.1016/j.jcin.2023.11.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 11/17/2023] [Indexed: 12/29/2023]
|
14
|
Okamoto N, Egami Y, Matsunaga-Lee Y, Yano M, Nishino M. Reply: DIRO: Useful Comparative Trial on Rotational vs Orbital Atherectomy, But There Are Caveats. JACC Cardiovasc Interv 2023; 16:2936. [PMID: 38092504 DOI: 10.1016/j.jcin.2023.10.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 10/24/2023] [Indexed: 12/18/2023]
|
15
|
Protty M, Hussain H, Hailan A, Choudhury A. DIRO: Useful Comparative Trial on Rotational vs Orbital Atherectomy, But There Are Caveats. JACC Cardiovasc Interv 2023; 16:2935. [PMID: 38092503 DOI: 10.1016/j.jcin.2023.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Accepted: 10/10/2023] [Indexed: 12/18/2023]
|
16
|
Florek K, Bartoszewska E, Biegała S, Klimek O, Malcharczyk B, Kübler P. Rotational Atherectomy, Orbital Atherectomy, and Intravascular Lithotripsy Comparison for Calcified Coronary Lesions. J Clin Med 2023; 12:7246. [PMID: 38068298 PMCID: PMC10707420 DOI: 10.3390/jcm12237246] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 10/30/2023] [Accepted: 11/08/2023] [Indexed: 10/16/2024] Open
Abstract
In order to improve the percutaneous treatment of coronary artery calcifications (CAC) before stent implantation, methods such as rotational atherectomy (RA), orbital atherectomy (OA), and coronary intravascular lithotripsy (IVL) were invented. These techniques use different mechanisms of action and therefore have various short- and long-term outcomes. IVL employs sonic waves to modify CAC, whereas RA and OA use a rapidly rotating burr or crown. These methods have specific advantages and limitations, regarding their cost-efficiency, the movement of the device, their usefulness given the individual anatomy of both the lesion and the vessel, and the risk of specified complications. This study reviews the key findings of peer-reviewed articles available on Google Scholar with the keywords RA, OA, and IVL. Based on the collected data, successful stent delivery was assessed as 97.7% for OA, 92.4% for IVL, and 92.5% for RA, and 30-day prevalence of MACE (Major Adverse Cardiac Events) in OA-10.4%, IVL-7.2%, and RA-5%. There were no significant differences in the 1-year MACE. Compared to RA, OA and IVL are cost-effective approaches, but this is substantially dependent on the reimbursement system of the particular country. There is no standard method of CAC modification; therefore, a tailor-made approach is required.
Collapse
Affiliation(s)
- Kamila Florek
- Students’ Scientific Group of Invasive Cardiology, Institute of Heart Diseases, Wroclaw Medical University, 50-369 Wroclaw, Poland; (E.B.); (S.B.); (O.K.); (B.M.)
| | - Elżbieta Bartoszewska
- Students’ Scientific Group of Invasive Cardiology, Institute of Heart Diseases, Wroclaw Medical University, 50-369 Wroclaw, Poland; (E.B.); (S.B.); (O.K.); (B.M.)
| | - Szymon Biegała
- Students’ Scientific Group of Invasive Cardiology, Institute of Heart Diseases, Wroclaw Medical University, 50-369 Wroclaw, Poland; (E.B.); (S.B.); (O.K.); (B.M.)
| | - Oliwia Klimek
- Students’ Scientific Group of Invasive Cardiology, Institute of Heart Diseases, Wroclaw Medical University, 50-369 Wroclaw, Poland; (E.B.); (S.B.); (O.K.); (B.M.)
| | - Bernadeta Malcharczyk
- Students’ Scientific Group of Invasive Cardiology, Institute of Heart Diseases, Wroclaw Medical University, 50-369 Wroclaw, Poland; (E.B.); (S.B.); (O.K.); (B.M.)
| | - Piotr Kübler
- Institute of Heart Diseases, Wroclaw University Hospital, 50-556 Wroclaw, Poland;
- Department of Cardiology, Faculty of Medicine, Institute of Heart Diseases, Wroclaw Medical University, 50-367 Wroclaw, Poland
| |
Collapse
|
17
|
Kereiakes DJ. Atheroablation Imaging Insights. JACC Cardiovasc Interv 2023; 16:2137-2138. [PMID: 37704300 DOI: 10.1016/j.jcin.2023.06.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Accepted: 06/26/2023] [Indexed: 09/15/2023]
Affiliation(s)
- Dean J Kereiakes
- Christ Hospital and Lindner Research Center, Cincinnati, Ohio, USA.
| |
Collapse
|